三环抗抑郁药作为潜在的α-Synucleinopathy战斗剂:蛋白质结合和抗聚合活性的证据
Bulat I Khairutdinov1, Diliara R Khaibrakhmanova2, Evgeniia V Leisi3
1Kazan Institute of Biochemistry and Biophysics, 420111 Kazan, Russia.
ACS chemical neuroscience
|January 23, 2026
概括
三环抗抑郁药物,如伊米普拉,与内在无序的蛋白质结合,如α-synuclein,抑制在帕金森病中涉及的动. 这一发现为神经退行性疾病提供了新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 包括α-synuclein在内的内在失调蛋白 (IDPs) 是帕金森氏症等神经退行性疾病的核心.
- 形灵活性和IDP缺乏明确的口袋对药物发现构成重大挑战.
研究的目的:
- 调查临床批准的三环抗抑郁药 (TCA) 与单体α-synuclein的直接结合.
- 为了确定TCA是否可以抑制α-synuclein纤维化,这是帕金森病的关键病理过程.
主要方法:
- 核磁共振 (NMR) 光谱技术,包括水LOGSY和化学转移扰动 (CSP).
- 分子动力学 (MD) 模拟以阐明结合机制和相互作用.
- 实验CSP数据与带抑制功效之间的相关性分析.
主要成果:
- TCA (伊米普拉胺,阿米特利普提林,多克西) 直接与单体α-synuclein结合,抑制其纤维化.
- 结合是不特定的,并针对C端域,由静电,pi堆叠和疏水相互作用驱动.
- 伊米普拉胺在测试TCA中显示出最高的抑制功效.
结论:
- TCA代表了开发针对α-synuclein聚合的新疗法的有希望的支架.
- MD模拟有效地描述了小分子和IDP之间的相互作用,有助于药物发现工作.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.5K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.5K
The Evidence for Evolution
47.7K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.7K
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Protein and Protein Structure
87.1K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
A protein's shape is critical to its function. For example, an enzyme...
87.1K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
535
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
535
The Equilibrium Binding Constant and Binding Strength
14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K


